Navigation Links
Avantium and BP Extend Strategic Partnership
Date:10/16/2007

AMSTERDAM, October 16 /PRNewswire/ -- Avantium, a leading technology company servicing the oil, chemicals and pharmaceutical industries, announces the three-year extension of the strategic research collaboration with BP, one of the world's largest energy companies.

Avantium provides innovative, high value-added R&D services and tools to the energy, chemicals and pharmaceutical industries, and has a long standing relationship with BP. The collaboration builds on the strategic relationship between BP and Avantium that was initiated in 2005. The strategic research collaboration in the area of purified terephthalic acid (PTA) is extended for a period of 3 years. During this period Avantium will apply its advanced high-throughput R&D technology, services and modeling capabilities in the research and technology portfolio of BP's PTA business.

Tom van Aken, Chief Executive Officer of Avantium: "We are very pleased to continue our strategic relationship with BP. Over the past years, the teams of BP and Avantium have successfully collaborated to apply our unique technological capabilities to BP's PTA business. The continuation of our joint efforts is an excellent proof of the added value of our technology and expertise."

Sue Davison, Business Technology Manager BP Aromatics and Acetyls: "This strategic collaboration with Avantium is consistent with BP's global technology position in PTA, and affirms our commitment to continue to employ leading technologies such as high-throughput R&D for continual improvement of our PTA business."

Profile Avantium

Avantium is a leading technology company in the area of advanced high-throughput R&D operating in the energy, chemicals and pharmaceutical industries. The company develops products and processes in the area of biofuels, bio-based chemicals and novel crystal forms of existing drugs by applying its proprietary, high-throughput R&D technology. Avantium has demonstrated the potential of this technol
'/>"/>

SOURCE Avantium Technologies B.V.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Medicare Drug Deadline not to be extended
2. Liver key to extending life
3. Regular exercise linked to extended menstrual cycles
4. Even mid-life diet change can extend life
5. Extended Therapy for Blood Clots
6. Friendship can extend lifespan
7. Genes to Extend Longevity Discovered
8. India extends National TB Control Program
9. Breast Cancer Funding To Be Extended By Another $30 Million: Pharmac
10. Drug Courts In Europe Extended For Three More Years
11. Single Dose Of Extended Release Metformin Found To Be Effective In Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...n to use a treadmill desk to prevent obesity: ov...AZ (PRWEB) January 8, 2009 -- Yet another alarm be...ng of America,s rising obesity rates and the corre...Institute completed a study that has shown a stati...eight gain and ovarian cancer. While obesity has p...
(Date:1/8/2009)...ians Practice and St. Mary Medical Center have joi...ir staff more time to devote to patient care. This...elp doctors in the Long Beach-Torrance area better...f managing a busy practice. Through this new allia...ractice,s extensive resources to deliver essential...
(Date:1/8/2009)...reas of B.C. are up to twice as likely to die from...ff areas, a University of British Columbia study h...the online journal Public Library of Science ONE ... lower socioeconomic neighbourhoods are more vulne...cancer. , "Even in a country with universal heal...
(Date:1/8/2009)... of three Certified Quality Breast Centers in the ...Breast Center at Houston Northwest Medical Center ... recognized as a Certified Quality Breast Center b... designation represents Houston Northwest Medical ...th care to their patients. , , Measuring and co...
Breaking Medicine News(10 mins):Health News:Treadmill Desks Combat Obesity Linked to Higher Rates of Ovarian Cancer 2Health News:Treadmill Desks Combat Obesity Linked to Higher Rates of Ovarian Cancer 3Health News:Physicians Practice and St. Mary Medical Center Partner to Improve Patient Care in Long Beach, CA 2Health News:Physicians Practice and St. Mary Medical Center Partner to Improve Patient Care in Long Beach, CA 3Health News:Mortality rates higher for heart disease patients in poorer B.C. neighborhoods 2Health News:Houston Northwest Medical Center Is Recognized as a Certified Quality Breast Center(TM) by the National Consortium of Breast Centers 2Health News:Houston Northwest Medical Center Is Recognized as a Certified Quality Breast Center(TM) by the National Consortium of Breast Centers 3
...uggested that Women with disproportionate or uneve...cancer. Fortunately// , the mammography is designe...st, the study has revealed. A University of Live...mmograms of 252 women who developed cancer were co...
...also known as ice has resulted in increasing numbe...e increasing number of cases// and they are strugg...ow that about one in four ice addicts have a psych...ital has recorded a five-fold increase in patients...
...chers from the University of Michigan and Harvard ...ogy to explore how different regions// of the brai...ies of brands and products. The study, forthcoming...is the first to use fMRI to assess consumer percep...
...irector Homi Adajania's English film "Being Cyrus"...depicting older women in roles that explore their ...bai film features Dimple Kapadia as Katy, a Parsi ... essayed by Saif Ali Khan. The film also stars Nas...
Other Medicine News:Health News:Needed, more space for women's sexual identity on marquees 2Health News:Needed, more space for women's sexual identity on marquees 3Health News:Needed, more space for women's sexual identity on marquees 4
(Date:12/27/2008)...N DIMAS, Calif., Dec. 27 According...e best advised to consume modest doses of,resvera...ically provided in 3,to 5 glasses of aged, red wi...: http://www.newscom.com/cgi-bin/prnh/20080603/L...a-dose resveratrol alone fails to prolong,the lif...
(Date:12/17/2008)...cientists show for the first time that normal stem...olid tissues , , MEMPHIS, Tenn., Dec. 17 /P...Children,s Research Hospital have answered a centr... cells can give rise to tumors. Stem cells are imm...e to mature differentiated cells that compose the ...
(Date:12/17/2008)...SCO, Dec. 17 Medivation,...as completed patient enrollment in a,Phase 1-2 do... androgen,receptor antagonist, in castration-resi...seek approval from the U.S. Food and Drug Administ...s next year. , The open-label, U.S. Phase 1...
(Date:12/17/2008)..., Calif., Dec. 17 Neurob...NTII ) today announced that an independent,Data S...the current clinical,trials of Viprinex(TM) for t...,to show benefit. As a result, the company has te...ll obtain and analyze the data before evaluating t...
Breaking Medicine Technology:Longevity Seekers Advised to Consume Modest Doses of Red Wine Molecules in Dietary Supplements (Longevinex(R)) Rather than Mega-Dose Resveratrol Alone 2Longevity Seekers Advised to Consume Modest Doses of Red Wine Molecules in Dietary Supplements (Longevinex(R)) Rather than Mega-Dose Resveratrol Alone 3Molecular Marker Identifies Normal Stem Cells as Intestinal Tumor Source 2Molecular Marker Identifies Normal Stem Cells as Intestinal Tumor Source 3Medivation Completes Enrollment of Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients 2Medivation Completes Enrollment of Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients 3Medivation Completes Enrollment of Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients 4Neurobiological Technologies Announces Viprinex(TM) Does Not Pass Interim Futility Analysis 2Country Music Star Trace Adkins to Be Honorary Chair of Nationwide Walk for Food Allergy 22782 1Country Music Star Trace Adkins to Be Honorary Chair of Nationwide Walk for Food Allergy 22782 2Country Music Star Trace Adkins to Be Honorary Chair of Nationwide Walk for Food Allergy 22782 3Catalyst Pharmaceutical Partners Inc Set to Join Russell Microcap 28R 29 Index 22777 1Catalyst Pharmaceutical Partners Inc Set to Join Russell Microcap 28R 29 Index 22777 2Catalyst Pharmaceutical Partners Inc Set to Join Russell Microcap 28R 29 Index 22777 3Journal of Antimicrobial Chemotherapy Paper Supports Additional Role for Cethromycin as Potential Treatment for Infections Caused by Community Associ 2523 1Journal of Antimicrobial Chemotherapy Paper Supports Additional Role for Cethromycin as Potential Treatment for Infections Caused by Community Associ 2523 2Journal of Antimicrobial Chemotherapy Paper Supports Additional Role for Cethromycin as Potential Treatment for Infections Caused by Community Associ 2523 3Journal of Antimicrobial Chemotherapy Paper Supports Additional Role for Cethromycin as Potential Treatment for Infections Caused by Community Associ 2523 4Journal of Antimicrobial Chemotherapy Paper Supports Additional Role for Cethromycin as Potential Treatment for Infections Caused by Community Associ 2523 5The AGA Foundation invests in gastroenterologys future 3763 1The AGA Foundation invests in gastroenterologys future 3763 2The AGA Foundation invests in gastroenterologys future 3763 3
...(BUSINESS WIRE)--Jun 25, 2007 - Elixir,Pharmaceuti...o sets,of preclinical data demonstrating that ghre...e treatment of a range of metabolic,disorders. The...olic effects, notably decreasing body weight, impr...reductions in fatty liver.,The data were presented...
...NESS WIRE)--Jun 25, 2007 - CytRx Corporation,(NASD...he,development and commercialization of human ther...esults from its previously,announced double-blind,... trial in healthy volunteers with its drug candida... this trial support,the use of arimoclomol in futu...
Other Medicine Technology:Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its,Ghrelin Antagonist Program at the American Diabetes Association's,Annual Meeting 2Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its,Ghrelin Antagonist Program at the American Diabetes Association's,Annual Meeting 3Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its,Ghrelin Antagonist Program at the American Diabetes Association's,Annual Meeting 4CytRx Announces Clinical Results from Its Rising Multiple Dose,Trial with Arimoclomol for ALS 2CytRx Announces Clinical Results from Its Rising Multiple Dose,Trial with Arimoclomol for ALS 3CytRx Announces Clinical Results from Its Rising Multiple Dose,Trial with Arimoclomol for ALS 4CytRx Announces Clinical Results from Its Rising Multiple Dose,Trial with Arimoclomol for ALS 5
The MICROsed-System is the ideal system back up support to be used as front-line instrument with small workloads.
The Sedimat 15 Automated sedrate system provides an accurate ESR result in only 15 minutes. Fast, in-office results (before patient leaves the office) can lead to improved patient therapy.
...g device for finger and alternate site testing fro... Comfort Zone Technology and Force Adjustment that... Comfort Zone Technology increases comfort when la... pain. This approach masks the pain of lancing to ...
Reduce the pain and hassle of testing. Unlike conventional lancing systems, the ACCU-CHEK Multiclix lancet device is the only one with a six-lancet drum. It offers the least painful testing, with les
Medicine Products: